Trends in the development of microfluidic cell biochips for in vitro hepatotoxicity

Current developments in the technological fields of liver tissue engineering, bioengineering, biomechanics, microfabrication and microfluidics have lead to highly complex and pertinent new tools called cell biochips for in vitro toxicology. The purpose of cell biochips is to mimic organ tissues in vitro in order to partially reduce the amount of in vivo testing. These cell biochips consist of microchambers containing engineered tissue and living cell cultures interconnected by a microfluidic network, which allows the control of microfluidic flows for dynamic cultures, by continuous feeding of nutrients to cultured cells and waste removal. Cell biochips also allow the control of physiological contact times of diluted molecules with the tissues and cells, for rapid testing of sample preparations or specific addressing. Cell biochips can be situated between in vitro and in vivo testing. These types of systems can enhance functionality of cells by mimicking the tissue architecture complexities when compared to in vitro analysis but at the same time present a more rapid and simple process when compared to in vivo testing procedures. In this paper, we first introduce the concepts of microfluidic and biochip systems based on recent progress in microfabrication techniques used to mimic liver tissue in vitro. This includes progress and understanding in biomaterials science (cell culture substrate), biomechanics (dynamic cultures conditions) and biology (tissue engineering). The development of new cell biochips for chronic toxicology analysis of engineered tissues can be achieved through the combination of these research domains. Combining these advanced research domains, we then present cell biochips that allow liver chronic toxicity analysis in vitro on engineered tissues. An extension of the cell biochip idea has also allowed organ interactions on chip, which can be considered as a first step towards the replacement of animal testing using a combined liver/lung organ model. (C) 2006 Elsevier Ltd. All rights reserved.